Search results
Earnings call: Adaptimmune outlines afami-cel launch and financials By Investing.com
Investing.com· 5 days agoAdaptimmune Therapeutics PLC (NASDAQ:ADAP), a biotechnology company specializing in T-cell therapy,...
Signs and Symptoms of Vulvar Cancer
Health via Yahoo News· 6 days agoThey can appear in different shapes and may have uneven coloring. Later signs of vulvar melanoma may include pain, itching, genital bleeding, or a lump...
Anti-inflammatory diet guide: Foods, benefits and meal plan
Daily Telegraph· 17 hours agoIgnore chronic inflammation at your peril. Recognised as a contributor to many deaths globally, half...
NCCN Publishes New Resource for Patients with Inte | Newswise
Newswise· 21 hours agoThis free resource for people facing cancer and caregivers is focused on a rare cancer type that...
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoWe plan to approach the FDA to discuss a BLA filing strategy if we determine nine responses by independent central review. As a reminder, we have received fast-track designation for enva in ...
'I was looking at my child, planning his funeral': The horror of the infected blood scandal, by the...
Daily Telegraph· 1 day agoThe infected blood scandal can only be described as a catalogue of heartbreak. More than 30,000...
Local boy becomes published author through Make-A-Wish Foundation
The Columbus Dispatch via Yahoo News· 3 days agoThe story follows Dash, a boy who awakens from a mysterious dream about a pulsating orb, only to...
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with...
Morningstar· 13 hours agoPRINCETON, NJ / ACCESSWIRE / May 20, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs ...
What Is The New Treatment Instead of Chemotherapy?
San Diego Red via Yahoo News· 6 days agoAmerica has qualified medical personnel to walk you through your cancer journey, but the prices are out-of-this-world. It’s extremely difficult to find...
Adaptimmune secures $125 million loan for cancer therapy By Investing.com
Investing.com· 5 days ago(NYSE: NYSE:HTGC). The agreement, revealed on Wednesday, is poised to bolster Adaptimmune's...
